24 November 2017
News and Views
Links and Services
A trial reported in the latest issue of the Alimentary Pharmacology & Therapeutics evaluates deep remission in biologic and immunomodulator naïve patients with Crohn's disease.
As treatment goals in Crohn's disease evolve, targets now include clinical remission, mucosal hea
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors